What is the newly approved hypoglycemic drug?

Invokana: Invokana is a novel drug that prevents reuptake of glucose from the kidney, so that you just shed more glucose out via the kidney. There are some concerns about it about long term cancer risk, as well as use in patients with kidney disease, so more studies are pending.

Canagloflozin: Invokana is a novel drug that prevents reuptake of glucose from the kidney, so that you just shed more glucose out via the kidney. Not effective with kidney disease, creatinine clearance <45. Drops hga1c ~0.8, both fasting and after-eating sugars. Must drink lots of liquids to prevent dizziness low blood pressure and, to reduce risk of urine infections, push fluids andkeep fastidious bathroom.